Author: Laurence Pendell - Page 2

Generic Drug Patents: Exclusivity Periods Across Countries Explained
21
Jan

Generic drug patents and exclusivity periods vary by country, affecting when affordable versions reach patients. The U.S., EU, Canada, and others have different rules on patent extensions, data protection, and generic incentives - with major impacts on drug prices and access.

Foodborne Illnesses: Common Pathogens and How to Stay Safe
20
Jan

Learn the most common foodborne pathogens like Salmonella, Listeria, and Norovirus, how they spread, and the simple steps you can take every day to protect yourself and your family from food poisoning.

Blue Light and Sleep: How to Limit Screen Time for Deeper Rest
19
Jan

Blue light from screens suppresses melatonin, delaying sleep and reducing quality. Limit screen time 1-2 hours before bed, use blue light filters, and replace scrolling with calm routines for deeper rest.

Teriparatide vs Abaloparatide for Osteoporosis: What You Need to Know in 2026
18
Jan

Teriparatide and abaloparatide are the only bone-building drugs for severe osteoporosis. Learn how they differ in effectiveness, safety, cost, and real-world outcomes in 2026.

Direct-to-Consumer Generic Pharmacies: How New Business Models Are Changing How You Get Medications
17
Jan

Direct-to-consumer generic pharmacies are cutting out middlemen to deliver affordable medications directly to patients. Learn how platforms like Ro and Honeybee Health are changing how people access common prescriptions-faster, cheaper, and with more transparency.

Autoimmune Disorder Medications: Understanding Immunosuppression Complications
16
Jan

Immunosuppressive drugs control autoimmune diseases but carry serious risks like infections, cancer, and organ damage. Learn which medications are safest, how to reduce complications, and what patients are really experiencing.

Generic vs Brand-Name Drugs: Key Differences Explained
14
Jan

Generic drugs work the same as brand-name versions but cost up to 85% less. Learn how the FDA ensures they're safe, when to stick with brand-name, and how to save money without sacrificing effectiveness.

FDA Listing for Biosimilars: How They Are Evaluated and Approved
13
Jan

The FDA doesn't rate biosimilars like consumer products-it evaluates them through rigorous scientific testing to ensure they're highly similar to reference biologics with no clinically meaningful differences in safety or effectiveness.

FDA Safety Standards: How Generic Drugs Meet Brand Name Drug Requirements
12
Jan

The FDA requires generic drugs to meet the same safety, strength, and effectiveness standards as brand-name drugs. Learn how bioequivalence, manufacturing rules, and strict testing ensure generics work just as well.

Contamination Controls: Preventing Adulteration in Generic Pharmaceuticals
11
Jan

Contamination controls in generic drug manufacturing prevent dangerous adulteration through strict cleanroom standards, real-time monitoring, and human process controls. Learn how facilities ensure safety without sacrificing affordability.

Manufacturing Transparency: How to Access FDA Inspection Records
10
Jan

Understand how FDA inspection records work, what manufacturers must disclose, and why transparency matters for drug safety. Learn about Form 483, remote inspections, and the real cost of compliance.

Triptans and SSRIs: The Truth About Serotonin Syndrome Risk
9
Jan

Despite a 2006 FDA warning, research shows triptans and SSRIs together do not significantly increase serotonin syndrome risk. Evidence from large patient studies confirms the combination is safe for migraine sufferers on antidepressants.